Attendees at our October 12 webinar had the invaluable opportunity to gain firsthand insights from two global authorities in the field of pulmonary hypertension. These distinguished experts, both co-authors of the 2022 European Society of Cardiology and European Respiratory Society clinical guidelines on pulmonary hypertension, shed light on the updated treatment algorithm outlined in the guidelines.
Prof. Marius Hoeper, Deputy Director of Respiratory Medicine at the Hannover Medical School, Germany
Prof. Olivier Sitbon, Professor of Respiratory Medicine at the Paris-Saclay University, France
Rob Pleticha of admedicum, experts in Patient Engagement and Access
- Pulmonary Arterial Hypertension (PAH) versus other forms of Pulmonary Hypertension
- The role of risk stratification in the management of patients with PAH
- Treatment strategies at time of diagnosis and follow-up, including the role of comorbidities
- Perspective of new treatment modalities
The webinar will be broadcast across on LinkedIn Live, Facebook Live, and YouTube, to ensure broad accessibility and participation. We are committed to preserving and sharing the wealth of information delivered during all the sessions. A comprehensive transcript will be made available after each webinar, allowing individuals to review and share the content with their networks. We recognise the importance of overcoming language barriers, and therefore, we will provide translations, on request, making these invaluable resources accessible to individuals from diverse linguistic backgrounds.